{"id":"https://openalex.org/W2090987624","doi":"https://doi.org/10.1016/0278-5846(91)90028-y","title":"Buprenorphine responders: A diagnostic subgroup of heroin addicts?","display_name":"Buprenorphine responders: A diagnostic subgroup of heroin addicts?","publication_year":1991,"publication_date":"1991-01-01","ids":{"openalex":"https://openalex.org/W2090987624","doi":"https://doi.org/10.1016/0278-5846(91)90028-y","mag":"2090987624","pmid":"https://pubmed.ncbi.nlm.nih.gov/1749829"},"language":"en","primary_location":{"id":"doi:10.1016/0278-5846(91)90028-y","doi":"https://doi.org/10.1016/0278-5846(91)90028-y","is_oa":true,"landing_page_url":"https://doi.org/10.1016/0278-5846(91)90028-y","pdf_url":null,"source":{"id":"https://openalex.org/S142279999","display_name":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","issn_l":"0278-5846","issn":["0278-5846","1878-4216"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.1016/0278-5846(91)90028-y","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5112137665","display_name":"Richard B. Resnick","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I57206974","display_name":"New York University","ror":"https://ror.org/0190ak572","country_code":"US","type":"education","lineage":["https://openalex.org/I57206974"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Richard B. Resnick","raw_affiliation_strings":["Department of Psychiatry, New York University School of Medicine, NY","Center for Psychiatry and Family Therapy, New York, NY, USA","Division of Alcoholism and Drug Abuse, Department of Psychiatry, New York University School of Medicine USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry, New York University School of Medicine, NY","institution_ids":["https://openalex.org/I57206974"]},{"raw_affiliation_string":"Center for Psychiatry and Family Therapy, New York, NY, USA","institution_ids":[]},{"raw_affiliation_string":"Division of Alcoholism and Drug Abuse, Department of Psychiatry, New York University School of Medicine USA","institution_ids":["https://openalex.org/I57206974"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065717428","display_name":"Elaine Resnick","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Elaine Resnick","raw_affiliation_strings":["Center for Psychiatry and Family Therapy, New York, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Psychiatry and Family Therapy, New York, NY, USA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5042048224","display_name":"Marc S. Galanter","orcid":"https://orcid.org/0000-0002-1978-4453","observed_orcids":["https://orcid.org/0000-0002-1978-4453"]},"institutions":[{"id":"https://openalex.org/I57206974","display_name":"New York University","ror":"https://ror.org/0190ak572","country_code":"US","type":"education","lineage":["https://openalex.org/I57206974"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Marc Galanter","raw_affiliation_strings":["Division of Alcoholism and Drug Abuse, Department of Psychiatry, New York University School of Medicine USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Alcoholism and Drug Abuse, Department of Psychiatry, New York University School of Medicine USA","institution_ids":["https://openalex.org/I57206974"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4380,"currency":"USD","value_usd":4380},"apc_paid":{"value":4380,"currency":"USD","value_usd":4380},"fwci":2.0077,"has_fulltext":false,"cited_by_count":34,"citation_normalized_percentile":{"value":0.87940538,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":96},"biblio":{"volume":"15","issue":"4","first_page":"531","last_page":"538"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10576","display_name":"Opioid Use Disorder Treatment","score":0.9940999746322632,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10576","display_name":"Opioid Use Disorder Treatment","score":0.9940999746322632,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10043","display_name":"Substance Abuse Treatment and Outcomes","score":0.00570000009611249,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11199","display_name":"Pain Management and Opioid Use","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2703","display_name":"Anesthesiology and Pain Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/buprenorphine","display_name":"buprenorphine","score":1.0},{"id":"https://openalex.org/keywords/heroin-dependence","display_name":"heroin addiction","score":0.953000009059906},{"id":"https://openalex.org/keywords/opioid-addiction-treatment","display_name":"opioid dependence treatment","score":0.7889999747276306},{"id":"https://openalex.org/keywords/treatment-response","display_name":"treatment response","score":0.6129999756813049},{"id":"https://openalex.org/keywords/psychosocial-functioning","display_name":"psychosocial functioning","score":0.7799999713897705},{"id":"https://openalex.org/keywords/methadone-maintenance-treatment","display_name":"methadone maintenance treatment","score":0.8980000019073486},{"id":"https://openalex.org/keywords/naltrexone","display_name":"naltrexone","score":0.9900000095367432},{"id":"https://openalex.org/keywords/mixed-agonist-antagonist-opioids","display_name":"mixed agonist-antagonist opioids","score":0.7540000081062317},{"id":"https://openalex.org/keywords/relapse","display_name":"relapse","score":0.656000018119812},{"id":"https://openalex.org/keywords/sublingual-formulation","display_name":"sublingual formulation","score":0.6809999942779541},{"id":"https://openalex.org/keywords/addiction-counseling","display_name":"addiction counseling","score":0.33000001311302185}],"concepts":[{"id":"https://openalex.org/C2778949969","wikidata":"https://www.wikidata.org/wiki/Q407721","display_name":"Buprenorphine","level":4,"score":0.9236657619476318},{"id":"https://openalex.org/C2777972943","wikidata":"https://www.wikidata.org/wiki/Q409587","display_name":"Naltrexone","level":4,"score":0.800687313079834},{"id":"https://openalex.org/C2778903686","wikidata":"https://www.wikidata.org/wiki/Q60168","display_name":"Heroin","level":3,"score":0.725091814994812},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6916625499725342},{"id":"https://openalex.org/C2778767360","wikidata":"https://www.wikidata.org/wiki/Q179996","display_name":"Methadone","level":2,"score":0.6771004796028137},{"id":"https://openalex.org/C150966472","wikidata":"https://www.wikidata.org/wiki/Q3410145","display_name":"Psychosocial","level":2,"score":0.6655744314193726},{"id":"https://openalex.org/C48856860","wikidata":"https://www.wikidata.org/wiki/Q12029","display_name":"Addiction","level":2,"score":0.5729740858078003},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.395550012588501},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.35613346099853516},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.3123331665992737},{"id":"https://openalex.org/C2781063702","wikidata":"https://www.wikidata.org/wiki/Q427523","display_name":"Opioid","level":3,"score":0.15768542885780334},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.14542633295059204},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002047","descriptor_name":"Buprenorphine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D002047","descriptor_name":"Buprenorphine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D002047","descriptor_name":"Buprenorphine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005500","descriptor_name":"Follow-Up Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006556","descriptor_name":"Heroin Dependence","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":false},{"descriptor_ui":"D006556","descriptor_name":"Heroin Dependence","qualifier_ui":"Q000534","qualifier_name":"rehabilitation","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010865","descriptor_name":"Pilot Projects","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012919","descriptor_name":"Social Behavior","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013375","descriptor_name":"Substance Withdrawal Syndrome","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/0278-5846(91)90028-y","doi":"https://doi.org/10.1016/0278-5846(91)90028-y","is_oa":true,"landing_page_url":"https://doi.org/10.1016/0278-5846(91)90028-y","pdf_url":null,"source":{"id":"https://openalex.org/S142279999","display_name":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","issn_l":"0278-5846","issn":["0278-5846","1878-4216"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","raw_type":"journal-article"},{"id":"pmid:1749829","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/1749829","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Progress in neuro-psychopharmacology & biological psychiatry","raw_type":"Case Reports"}],"best_oa_location":{"id":"doi:10.1016/0278-5846(91)90028-y","doi":"https://doi.org/10.1016/0278-5846(91)90028-y","is_oa":true,"landing_page_url":"https://doi.org/10.1016/0278-5846(91)90028-y","pdf_url":null,"source":{"id":"https://openalex.org/S142279999","display_name":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","issn_l":"0278-5846","issn":["0278-5846","1878-4216"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.98580002784729,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":10,"referenced_works":["https://openalex.org/W1966282663","https://openalex.org/W1989887935","https://openalex.org/W2035860618","https://openalex.org/W2061161214","https://openalex.org/W2063539450","https://openalex.org/W2068839310","https://openalex.org/W2087259361","https://openalex.org/W2091692004","https://openalex.org/W2133801459","https://openalex.org/W2981348329"],"related_works":["https://openalex.org/W2408959424","https://openalex.org/W1973442201","https://openalex.org/W2047728793","https://openalex.org/W2171737529","https://openalex.org/W2964030416","https://openalex.org/W2057644514","https://openalex.org/W2019673287","https://openalex.org/W1984034962","https://openalex.org/W2087259361","https://openalex.org/W2050443628"],"abstract_inverted_index":{"1.":[0],"A":[1,225],"26-32":[2],"month":[3],"follow-up":[4],"of":[5,14,31,36,98,125,171,195,204,228,239],"16":[6,100],"heroin-dependent":[7],"subjects":[8],"who":[9,78],"entered":[10],"a":[11,29,62,86,123,137,169],"pilot":[12],"trial":[13],"treatment":[15,26,144,190],"with":[16,136],"buprenorphine":[17,110,210,229],"(a":[18,46,51],"mixed":[19],"agonist/antagonist)":[20],"suggests":[21],"that":[22],"positive":[23],"response":[24],"to":[25,231],"may":[27],"identify":[28],"subgroup":[30],"untreated":[32],"addicts":[33,77],"whose":[34],"levels":[35],"psychosocial":[37,196],"functioning":[38,197,205],"are":[39],"intermediate":[40],"between":[41],"those":[42],"for":[43,68,75,122,145,168,191,209,234],"whom":[44],"methadone":[45,82],"pure":[47,52],"agonist)":[48],"or":[49,90],"naltrexone":[50,94,151],"antagonist)":[53],"would":[54],"be":[55,91,232],"indicated.":[56],"2.":[57],"Buprenorphine's":[58],"pharmacologic":[59],"profile":[60],"provides":[61],"missing":[63],"link":[64],"in":[65],"available":[66],"modalities":[67],"opiate":[69],"dependence":[70],"treatment,":[71,84,152,236],"making":[72],"it":[73,156],"acceptable":[74],"many":[76],"will":[79],"not":[80],"accept":[81],"maintenance":[83],"join":[85],"residential":[87],"therapeutic":[88],"community,":[89],"successful":[92],"on":[93],"treatment.":[95],"3.":[96],"Eight":[97],"the":[99],"ss":[101],"were":[102,132,183,206],"abstinent":[103],"from":[104],"heroin":[105,120,166],"while":[106],"receiving":[107],"0.6-3.9":[108],"mg/day":[109],"and":[111,147,157,185,201,218,242],"counseling.":[112],"Responders":[113],"(mean":[114,160],"age":[115,161],"34":[116],"yrs)":[117,163],"had":[118,141,149,154,164,178,187],"been":[119,165],"dependent":[121,167],"mean":[124,170],"9.5":[126],"years":[127],"(range":[128,174],"6-17":[129],"yrs),":[130,176],"all":[131,182],"self-supporting,":[133],"4":[134],"lived":[135],"non-addicted":[138],"spouse,":[139],"5":[140],"no":[142,179,188],"prior":[143,150,189],"addiction":[146,235],"3":[148],"but":[153],"discontinued":[155],"relapsed.":[158],"Non-responders":[159],"30":[162],"7.4":[172],"yrs":[173],"2-19":[175],"7":[177,186],"regular":[180],"employment,":[181],"single":[184],"addiction.":[192],"4.":[193],"Levels":[194],"(work,":[198],"home,":[199],"leisure)":[200],"global":[202],"assessments":[203],"significantly":[207],"higher":[208],"responders":[211],"than":[212,216,221],"non-responders":[213],"(p":[214],"less":[215,220],".001":[217],"p":[219],".01":[222],"respectively).":[223],"5.":[224],"new":[226],"formulation":[227],"needs":[230],"developed":[233],"ideally":[237],"consisting":[238],"0.5":[240],"mg":[241,244],"2.0":[243],"sublingual":[245],"tablets.":[246]},"counts_by_year":[{"year":2019,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}